| Literature DB >> 17803052 |
Robert T Dauchy1, Erin M Dauchy, Leslie K Davidson, Jean A Krause, Darin T Lynch, Paul C Tirrell, Robert P Tirrell, Leonard A Sauer, Peter Van der Riet, David E Blask.
Abstract
Melatonin and eicosapentaenoic and 10t,12c-conjugated linoleic acids suppress the growth-stimulating effects of linoleic acid (LA) and its metabolism to the mitogenic agent 13-(S)-hydroxyoctadecadienoic acid (13-(S)-HODE) in established rodent tumors and human cancer xenografts. Here we compared the effects of these 3 inhibitory agents on growth and LA uptake and metabolism in human FaDu squamous cell carcinoma xenografts perfused in situ in male nude rats. Results demonstrated that these agents caused rapid inhibition of LA uptake, tumor cAMP content, 13-(S)-HODE formation, extracellular signal-regulated kinase p44/ p42 (ERK 1/2) activity, mitogen-activated protein kinase kinase (MEK) activity, and [3H]thymidine incorporation into tumor DNA. Melatonin's inhibitory effects were reversible with either the melatonin receptor antagonist S20928, pertussis toxin, forskolin, or 8-bromoadenosine-cAMP, suggesting that its growth-inhibitory effect occurs in vivo via a receptor-mediated, pertussis-toxin-sensitive pathway.Entities:
Mesh:
Substances:
Year: 2007 PMID: 17803052
Source DB: PubMed Journal: Comp Med ISSN: 1532-0820 Impact factor: 0.982